AI assistant
Sending…
Pulmonx Corp — Director's Dealing 2022
Nov 15, 2022
34428_dirs_2022-11-14_b4937640-a0d1-42da-8c6a-c2370a2761f4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2022-11-14
Reporting Person: French Glendon E. III (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-14 | Common Stock | M | 10000 | $2.20 | Acquired | 1037944 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-11-14 | Employee Stock Option (Right to Buy) | $2.20 | M | 10000 | Disposed | 2030-08-27 | Common Stock (10000) | Direct |
Footnotes
F1: The shares subject to the option are immediately exercisable and vest in 48 equal monthly installments beginning on August 28, 2020, subject to the Reporting Person's continuous service through each such vesting date.
More from Pulmonx Corp
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 4
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2025
Dec 11
Director's Dealing
2025
Dec 9
Regulatory Filings
2025
Dec 9
Director's Dealing
2025
Dec 4
Director's Dealing
2025
Dec 4